📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
SHUKRA PHARMACEUTICALS LIMITEDSHUKRAPHARPharmaceuticals
Open
30.34
High
31.85
Low
30
Close
31.85
Volume
212064
Exchange
bse
Time
01-Apr-2026

Outlook

Score:

5.5

Rating:

FAIR

Candlestick Pattern

CandlepatternofShukraPharmaceuticalsis
Closing Marubozu
EstimatedStoplossofShukraPharmaceuticalsis
30
ShukraPharmaceuticalshasa
Bullishℹ
pattern.
Formationof
Closing Marubozu
candlepatternindicatesShukraPharmaceuticalshaschancesof
Reversalℹ
touptrend

Trend

ShukraPharmaceuticalsisin
Downtrendℹ
.
PriceofShukraPharmaceuticalsis
Downℹ
by

19.71

%.
Target
Buy@

30.34

Sell@

40.82

Current@

31.85

Volume

ThetradevolumesofShukraPharmaceuticalshavebecome
Deficientℹ
ThevolumetrendforShukraPharmaceuticalsis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofShukraPharmaceuticalsis

Down

by

22.3

%

Valuation

ThecurrentmarketpriceofShukraPharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth86crandtotalassetsworth86cr,thebalancesheetofShukraPharmaceuticalsis:
Balancedℹ
.
Cashflow
ShukraPharmaceuticalshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 2cr

.Itis
Downℹ
by

66.67

%.
58.33% i.e. ₹ 7cr earned in operatingℹ
8.33% i.e. ₹ 1cr spent in investingℹ
33.33% i.e. ₹ 4cr spent in financingℹ
0% in otherℹ
ShukraPharmaceuticalshas
Excellentℹ
cashflowbecausethereis

Surplus

of

₹ 6cr

.Itis
Upℹ
by

100

%.
27.78% i.e. ₹ 5cr spent in operatingℹ
5.56% i.e. ₹ 1cr spent in investingℹ
66.67% i.e. ₹ 12cr earned in financingℹ
0% in otherℹ
Income
TheincomeofShukraPharmaceuticalsis

₹ 7cr

and

Profit

is:

₹ 2cr

ShukraPharmaceuticalsProfitisupby:

100

%andIncomeisUpby:

16.67

%
TheincomeofShukraPharmaceuticalsis

₹ 6cr

and

Profit

is:

₹ 1cr

ShukraPharmaceuticalsProfitisdownby:

80

%andIncomeisDownby:

57.14

%
TheincomeofShukraPharmaceuticalsis

₹ 14cr

and

Profit

is:

₹ 5cr

ShukraPharmaceuticalsProfitisupby:

66.67

%andIncomeisUpby:

27.27

%
By using this site you agree to the use of cookies to deliver a better site experience.